A detailed history of Jupiter Asset Management LTD transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Jupiter Asset Management LTD holds 23,133 shares of ITOS stock, worth $185,064. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,133
Previous 23,133 -0.0%
Holding current value
$185,064
Previous $343,000 31.2%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$8.57 - $11.06 $64,900 - $83,757
-7,573 Reduced 24.66%
23,133 $253,000
Q3 2023

Nov 09, 2023

SELL
$10.95 - $14.6 $199,454 - $265,939
-18,215 Reduced 37.23%
30,706 $336,000
Q1 2023

May 10, 2023

SELL
$13.02 - $22.62 $121,320 - $210,773
-9,318 Reduced 16.0%
48,921 $665,000
Q4 2022

Feb 10, 2023

BUY
$17.77 - $21.6 $640,555 - $778,615
36,047 Added 162.43%
58,239 $1.14 Million
Q3 2022

Nov 10, 2022

BUY
$18.6 - $27.25 $412,771 - $604,732
22,192 New
22,192 $423,000

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $285M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Jupiter Asset Management LTD Portfolio

Follow Jupiter Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jupiter Asset Management LTD with notifications on news.